Analysts expect Emergent BioSolutions Inc. to report revenue of 129.46 M for Q4 26, against a range of 116.65 M to 142.26 M. The most recent reported quarter, Q3 26, came in at 110.00 M, a 8.4% miss against the 120.04 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 194.70 M | 222.20 M | 140.90 M | 231.10 M | 148.70 M | 156.10 M | 234.30 M | 110.00 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 252.78 M | 248.30 M | 162.37 M | 197.92 M | 216.30 M | 159.99 M | 203.70 M | 125.24 M | 142.26 M | 173.06 M | 231.10 M | 227.26 M | 181.38 M | 161.37 M | 166.91 M | 197.48 M | |||||||||
| Low Estimate | 232.71 M | 208.11 M | 149.62 M | 180.87 M | 200.85 M | 140.83 M | 169.07 M | 114.85 M | 116.65 M | 162.96 M | 193.08 M | 188.37 M | 168.30 M | 138.38 M | 146.00 M | 170.68 M | |||||||||
| Consensus Estimate | 242.74 M | 228.21 M | 155.99 M | 189.40 M | 208.57 M | 150.41 M | 186.39 M | 120.04 M | 129.46 M | 168.01 M | 212.09 M | 207.81 M | 174.84 M | 149.88 M | 156.45 M | 184.08 M |
Analysts expect Emergent BioSolutions Inc. to report earnings per share of -0.17 for Q4 26, against a range of -0.18 to -0.16. The most recent reported quarter, Q3 26, came in at -0.36 , in line with the -0.36 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.05 | 0.71 | 0.16 | 1.06 | -0.43 | 0.21 | 0.60 | -0.36 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.50 | 0.49 | -0.47 | -0.12 | 0.11 | -0.22 | -0.09 | -0.32 | -0.16 | -0.04 | 0.31 | 0.28 | -0.18 | 0.38 | 0.70 | 0.59 | |||||||||
| Low Estimate | -0.54 | 0.43 | -0.55 | -0.14 | 0.11 | -0.26 | -0.11 | -0.40 | -0.18 | -0.04 | 0.27 | 0.24 | -0.22 | 0.34 | 0.58 | 0.51 | |||||||||
| Consensus Estimate | -0.52 | 0.46 | -0.51 | -0.13 | 0.11 | -0.24 | -0.10 | -0.36 | -0.17 | -0.04 | 0.29 | 0.26 | -0.20 | 0.36 | 0.64 | 0.55 |
Pull Wall Street consensus for Emergent BioSolutions Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=EBS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "EBS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=EBS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();